Kinuyo Chikamatsu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kinuyo Chikamatsu has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Satoshi Mitarai
The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association
16 shared publications - Akio Aono
Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
7 shared publications - Hiroyuki Yamada
Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
6 shared publications - Akiko Takaki
Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose-shi, Tokyo, Japan
4 shared publications Akio Aono
Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-tuberculosis Association, Kiyose, Japan
4 shared publicationsHiroyuki Yamada
4 shared publications
Latest Publications
- 26 February 2025
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (4) , 102665
Mycobacterium goodii pulmonary disease in an immunocompetent patient: A case report and literature review
- 26 February 2025
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (4) , 102665
Mycobacterium goodii pulmonary disease in an immunocompetent patient: A case report and literature review
- Open Access
- 1 February 2025
- Published by International Union Against Tuberculosis and Lung Disease in IJTLD OPEN
- Vol. 2 (2) , 96-100
Assessing the accuracy of the updated Fujifilm SILVAMP TB LAM II assay between lot numbers
SUMMARY: BACKGROUND: The Fujifilm SILVAMP TB LAM (FujiLAM) assay, a point-of-care test detecting urine-based lipoarabinomannans, has demonstrated notable diagnostic accuracy for TB. However, FujiLAM exhibits lot-to-lot variability, limiting its clinical use. A new version of the product, Fujifilm SILVAMP TB LAM II (FujiLAM II), was developed to address this issue. This study evaluated the lot-to-lot variability and diagnostic accuracy of the FujiLAM II. METHODS: We assessed three lots of FujiLAM II using 158 biobanked, frozen urine specimens from people living with HIV (PLHIV): 72 TB-positive and 86 TB-negative, according to the microbiological reference standard. RESULTS: Independent proportions of the results among the three FujiLAM II lots did not differ (Cochrane Q test: P > 0.37). Overall, sensitivities of the three FujiLAM II lots were 78.3%, 79.7% and 79.7%, and specificities were 92.9%, 93.0% and 93.0%, respectively. In patients with CD4 cell counts <200 cells/µL, sensitivities of the three FujiLAM II lots were 97.8%, 100% and 100%, and specificities were 91.7%, 91.8% and 91.8%, respectively. CONCLUSION: The FujiLAM II demonstrated no lot-to-lot variability and exhibited high sensitivity and specificity for TB diagnosis in patients with CD4 cell counts <200 cells/µL. The FujiLAM II enhanced reproducibility as a TB diagnostic tool in PLHIV.
- 1 February 2025
- Published by International Union Against Tuberculosis and Lung Disease in IJTLD OPEN
- Vol. 2 (2) , 96-100
Open AccessAssessing the accuracy of the updated Fujifilm SILVAMP TB LAM II assay between lot numbers
SUMMARY: BACKGROUND: The Fujifilm SILVAMP TB LAM (FujiLAM) assay, a point-of-care test detecting urine-based lipoarabinomannans, has demonstrated notable diagnostic accuracy for TB. However, FujiLAM exhibits lot-to-lot variability, limiting its clinical use. A new version of the product, Fujifilm SILVAMP TB LAM II (FujiLAM II), was developed to address this issue. This study evaluated the lot-to-lot variability and diagnostic accuracy of the FujiLAM II. METHODS: We assessed three lots of FujiLAM II using 158 biobanked, frozen urine specimens from people living with HIV (PLHIV): 72 TB-positive and 86 TB-negative, according to the microbiological reference standard. RESULTS: Independent proportions of the results among the three FujiLAM II lots did not differ (Cochrane Q test: P > 0.37). Overall, sensitivities of the three FujiLAM II lots were 78.3%, 79.7% and 79.7%, and specificities were 92.9%, 93.0% and 93.0%, respectively. In patients with CD4 cell counts <200 cells/µL, sensitivities of the three FujiLAM II lots were 97.8%, 100% and 100%, and specificities were 91.7%, 91.8% and 91.8%, respectively. CONCLUSION: The FujiLAM II demonstrated no lot-to-lot variability and exhibited high sensitivity and specificity for TB diagnosis in patients with CD4 cell counts <200 cells/µL. The FujiLAM II enhanced reproducibility as a TB diagnostic tool in PLHIV.
- Open Access
- 28 September 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (11) , 5756-5764
Diagnostic accuracy of 3 urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients
BACKGROUND. Inadequate tuberculosis (TB) diagnostics are a major hurdle in the reduction of disease burden, and accurate point-of-care tests (POCTs) are urgently needed. We assessed the diagnostic accuracy of Fujifilm SILVAMP TB lipoarabinomannan (FujiLAM) POCT for TB diagnosis in HIV-negative outpatients and compared it with Alere Determine TB LAM Ag (AlereLAM) POCT and a laboratory-based ultrasensitive electrochemiluminescence LAM research assay (EclLAM). METHODS. In this multicenter diagnostic test accuracy study, we recruited HIV-negative adults with symptoms suggestive of pulmonary TB presenting to outpatient health care centers in Peru and South Africa. Urine samples were tested using FujiLAM, AlereLAM, and EclLAM, and the diagnostic accuracy was assessed against a microbiological reference standard (MRS) and a composite reference standard. RESULTS. Three hundred seventy-two HIV-negative participants were included and the prevalence of microbiologically confirmed TB was 30%. Compared with the MRS, the sensitivities of AlereLAM, FujiLAM, and EclLAM were 10.8% (95% confidence interval [CI] 6.3%–18.0%), 53.2% (95% CI 43.9%–62.1%), and 66.7% (95% CI 57.5%–74.7%), respectively. The specificities of AlereLAM, FujiLAM, and EclLAM were 92.3% (95% CI 88.5%–95.0%), 98.9% (95% CI 96.7%–99.6%), and 98.1% (95% CI 95.6%–99.2%), respectively. Positive likelihood ratios of AlereLAM, FujiLAM, and EclLAM were 1.4, 46.2, and 34.8, respectively, and positive predictive values were 37.5%, 95.2%, and 93.7%, respectively. CONCLUSION. Compared with AlereLAM, FujiLAM detected 5 times more patients with TB in HIV-negative participants, had a high positive predictive value, and has the potential to improve rapid diagnosis of TB at the point-of-care. EclLAM demonstrated that additional sensitivity gains are possible, which highlights LAM’s potential as a biomarker. Additional research is required to assess FujiLAM’s performance in prospective cohorts, its cost-effectiveness, and its impact in real-world clinical settings. FUNDING. Global Health Innovative Technology Fund, the UK Department for International Development, the Dutch Ministry of Foreign Affairs, the Bill and Melinda Gates Foundation, the Australian Department of Foreign Affairs and Trade, the German Federal Ministry of Education and Research through Kreditanstalt für Wiederaufbau, and the NIH and National Institute of Allergy and Infectious Diseases.
- 28 September 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (11) , 5756-5764
Open AccessDiagnostic accuracy of 3 urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients
BACKGROUND. Inadequate tuberculosis (TB) diagnostics are a major hurdle in the reduction of disease burden, and accurate point-of-care tests (POCTs) are urgently needed. We assessed the diagnostic accuracy of Fujifilm SILVAMP TB lipoarabinomannan (FujiLAM) POCT for TB diagnosis in HIV-negative outpatients and compared it with Alere Determine TB LAM Ag (AlereLAM) POCT and a laboratory-based ultrasensitive electrochemiluminescence LAM research assay (EclLAM). METHODS. In this multicenter diagnostic test accuracy study, we recruited HIV-negative adults with symptoms suggestive of pulmonary TB presenting to outpatient health care centers in Peru and South Africa. Urine samples were tested using FujiLAM, AlereLAM, and EclLAM, and the diagnostic accuracy was assessed against a microbiological reference standard (MRS) and a composite reference standard. RESULTS. Three hundred seventy-two HIV-negative participants were included and the prevalence of microbiologically confirmed TB was 30%. Compared with the MRS, the sensitivities of AlereLAM, FujiLAM, and EclLAM were 10.8% (95% confidence interval [CI] 6.3%–18.0%), 53.2% (95% CI 43.9%–62.1%), and 66.7% (95% CI 57.5%–74.7%), respectively. The specificities of AlereLAM, FujiLAM, and EclLAM were 92.3% (95% CI 88.5%–95.0%), 98.9% (95% CI 96.7%–99.6%), and 98.1% (95% CI 95.6%–99.2%), respectively. Positive likelihood ratios of AlereLAM, FujiLAM, and EclLAM were 1.4, 46.2, and 34.8, respectively, and positive predictive values were 37.5%, 95.2%, and 93.7%, respectively. CONCLUSION. Compared with AlereLAM, FujiLAM detected 5 times more patients with TB in HIV-negative participants, had a high positive predictive value, and has the potential to improve rapid diagnosis of TB at the point-of-care. EclLAM demonstrated that additional sensitivity gains are possible, which highlights LAM’s potential as a biomarker. Additional research is required to assess FujiLAM’s performance in prospective cohorts, its cost-effectiveness, and its impact in real-world clinical settings. FUNDING. Global Health Innovative Technology Fund, the UK Department for International Development, the Dutch Ministry of Foreign Affairs, the Bill and Melinda Gates Foundation, the Australian Department of Foreign Affairs and Trade, the German Federal Ministry of Education and Research through Kreditanstalt für Wiederaufbau, and the NIH and National Institute of Allergy and Infectious Diseases.
- 1 August 2019
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 163, 105657
Evaluation of Q Gene Mycobacteria: A novel and easy nucleic acid chromatography method for mycobacterial species identification
- 1 August 2019
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 163, 105657
Evaluation of Q Gene Mycobacteria: A novel and easy nucleic acid chromatography method for mycobacterial species identification
- 1 August 2019
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 25 (8) , 610-614
A case of Mycobacterium tuberculosis laboratory cross-contamination
- 1 August 2019
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 25 (8) , 610-614
A case of Mycobacterium tuberculosis laboratory cross-contamination
- Open Access
- 1 December 2018
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 155, 34-36
Six species of nontuberculous mycobacteria carry non-identical 16S rRNA gene copies
- 1 December 2018
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 155, 34-36
Open AccessSix species of nontuberculous mycobacteria carry non-identical 16S rRNA gene copies
- 26 October 2018
- Published by Oxford University Press (OUP) in Microscopy
- Vol. 67 (suppl_2) , i32
PB-01Comparison of fundamental morphological properties between species belonging to genera Mycobacterium, Mycobacteroides and Mycolicibacterium
Former genus Mycobacterium has been divided into emended genus Mycobacterium and four novel genera recently [1]. We compared fundamental morphological properties of 20 species belonging to former Mycobacterium and two of four novel genera, Mycobacteroides and Mycolicibacterium. Mycobacterium tuberculosis H37Rv (ATCC 27294), M. avium (25291), M. celatum (31150), M. celatum (31151), M. gordonae (14470), M. intermedium (51848), M. intracellulare (13950), M. marinum (927), M. scrofulaceum (19981), M. ulcerans (19423), and M. xenopi (19520), Mycobacteroides abscessus (23006), M. chelonae (35749), Mycolicibacterium aurum (23366), M. austroafricanum (33464), M. chitae (19627), M. fortuitum (11440), M. fortuitum (6841), M. gilvum (43909), M. smegmatis (19420) were used. Bacilli were cultured liquid medium, and bacterial cells were fixed with 2.5% glutaraldehyde and rinsed with phosphate buffer. Samples were quickly frozen and examined with cryoTEM. TEM Images were analyzed with Fiji/ImageJ. Average cell diameter and length of Mycolicibacterium sp. were significantly larger than those of Mycobacterium sp. and Mycobacteroides sp. (both, p < 0.00001). On the other hand, average cell circularity of Mycobacteroides sp. was significantly larger than Mycobacterium sp. and Mycolicibacterium sp. (both, p < 0.05).
- 26 October 2018
- Published by Oxford University Press (OUP) in Microscopy
- Vol. 67 (suppl_2) , i32
PB-01Comparison of fundamental morphological properties between species belonging to genera Mycobacterium, Mycobacteroides and Mycolicibacterium
Former genus Mycobacterium has been divided into emended genus Mycobacterium and four novel genera recently [1]. We compared fundamental morphological properties of 20 species belonging to former Mycobacterium and two of four novel genera, Mycobacteroides and Mycolicibacterium. Mycobacterium tuberculosis H37Rv (ATCC 27294), M. avium (25291), M. celatum (31150), M. celatum (31151), M. gordonae (14470), M. intermedium (51848), M. intracellulare (13950), M. marinum (927), M. scrofulaceum (19981), M. ulcerans (19423), and M. xenopi (19520), Mycobacteroides abscessus (23006), M. chelonae (35749), Mycolicibacterium aurum (23366), M. austroafricanum (33464), M. chitae (19627), M. fortuitum (11440), M. fortuitum (6841), M. gilvum (43909), M. smegmatis (19420) were used. Bacilli were cultured liquid medium, and bacterial cells were fixed with 2.5% glutaraldehyde and rinsed with phosphate buffer. Samples were quickly frozen and examined with cryoTEM. TEM Images were analyzed with Fiji/ImageJ. Average cell diameter and length of Mycolicibacterium sp. were significantly larger than those of Mycobacterium sp. and Mycobacteroides sp. (both, p < 0.00001). On the other hand, average cell circularity of Mycobacteroides sp. was significantly larger than Mycobacterium sp. and Mycolicibacterium sp. (both, p < 0.05).
- 20 July 2018
- Published by Japan Veterinary Medical Association in Journal of the Japan Veterinary Medical Association
- Vol. 71 (7) , 369-375
Outbreak of Tuberculosis in Cynomolgus Monkeys (Macaca fascicularis) Imported to Japan
日本に輸入され,動物検疫所において検疫を実施していたカニクイザル32例において,ツベルクリン反応検査を実施したところ,9例が陽性または擬陽性と判定された.結核症が疑われる臨床症状は認められなかったが,病理組織学的に,肺,縦隔リンパ節等の臓器で抗酸菌を伴う結節性病変が認められ,細菌学的に,これらの臓器からMycobacterium tuberculosis(結核菌)が分離された.ツベルクリン反応検査及び病理学的検査の結果から,当該カニクイザル群に結核菌が数カ月以上前に侵入した後,同群内に伝播し拡散した状態にあったものと推察された.さらに,スポリゴタイピングにより遺伝子型別を実施したところ,分離菌の遺伝子型はEAI2_MANILLAと判定された.
- 20 July 2018
- Published by Japan Veterinary Medical Association in Journal of the Japan Veterinary Medical Association
- Vol. 71 (7) , 369-375
Outbreak of Tuberculosis in Cynomolgus Monkeys (Macaca fascicularis) Imported to Japan
日本に輸入され,動物検疫所において検疫を実施していたカニクイザル32例において,ツベルクリン反応検査を実施したところ,9例が陽性または擬陽性と判定された.結核症が疑われる臨床症状は認められなかったが,病理組織学的に,肺,縦隔リンパ節等の臓器で抗酸菌を伴う結節性病変が認められ,細菌学的に,これらの臓器からMycobacterium tuberculosis(結核菌)が分離された.ツベルクリン反応検査及び病理学的検査の結果から,当該カニクイザル群に結核菌が数カ月以上前に侵入した後,同群内に伝播し拡散した状態にあったものと推察された.さらに,スポリゴタイピングにより遺伝子型別を実施したところ,分離菌の遺伝子型はEAI2_MANILLAと判定された.
- Open Access
Six species of non-tuberculosis mycobacteria carry non-identical 16S rRNA gene copies
Non-tuberculosis mycobacteria (NTM) can carry two or more 16S rRNA gene copies that are, in some instances, non-identical. In this study, we used a combined cloning and sequencing approach to analyze the 16S rRNA gene sequences of six NTM species, Mycobacterium cosmeticum, M. pallens, M. hodleri, M. crocinum, M. flavescens , and M. xenopi . The approach facilitated the identification of two distinct gene copies in each species. The two M. cosmeticum genes had a single nucleotide difference, whereas two nucleotide polymorphisms were identified in M. hodleri, M. flavescens , and M. xenopi. M. pallens had a difference in four nucleotides and M. crocinum in 23. Hence, we showed that the six NTM species possess at least two non-identical 16S rRNA gene copies. Importance: The presence of multiple 16S rRNA gene copies with nucleotide polymorphisms represents a challenge for species identification using 16S rRNA as the target sequence. Our analysis was focused on six NTM species, M. cosmeticum, M. pallens, M. hodleri, M. crocinum, M. flavescens , and M. xenopi . As a result, we generated the full-length sequences of two non-identical 16S rRNA copies for each NTM species. The data will be helpful for the sequence analysis of specimens or other samples.
Open AccessSix species of non-tuberculosis mycobacteria carry non-identical 16S rRNA gene copies
Non-tuberculosis mycobacteria (NTM) can carry two or more 16S rRNA gene copies that are, in some instances, non-identical. In this study, we used a combined cloning and sequencing approach to analyze the 16S rRNA gene sequences of six NTM species, Mycobacterium cosmeticum, M. pallens, M. hodleri, M. crocinum, M. flavescens , and M. xenopi . The approach facilitated the identification of two distinct gene copies in each species. The two M. cosmeticum genes had a single nucleotide difference, whereas two nucleotide polymorphisms were identified in M. hodleri, M. flavescens , and M. xenopi. M. pallens had a difference in four nucleotides and M. crocinum in 23. Hence, we showed that the six NTM species possess at least two non-identical 16S rRNA gene copies. Importance: The presence of multiple 16S rRNA gene copies with nucleotide polymorphisms represents a challenge for species identification using 16S rRNA as the target sequence. Our analysis was focused on six NTM species, M. cosmeticum, M. pallens, M. hodleri, M. crocinum, M. flavescens , and M. xenopi . As a result, we generated the full-length sequences of two non-identical 16S rRNA copies for each NTM species. The data will be helpful for the sequence analysis of specimens or other samples.
- 1 January 2018
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 90 (1) , 35-39
Evaluation of PyroMark Q24 pyrosequencing as a method for the identification of mycobacteria
- 1 January 2018
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 90 (1) , 35-39
Evaluation of PyroMark Q24 pyrosequencing as a method for the identification of mycobacteria